Chiron Health AI Revolutionizes Chronic Disease Management
Chiron Health AI, a pioneering health-tech startup that has emerged from the bustling environment of Founders Factory, is making significant strides in revolutionizing chronic disease management. Based in London, UK, the company has successfully completed its pre-seed funding round, with SFC Capital leading this important initiative. The secured funding will empower Chiron Health AI to fast-track the development of its fully integrated business-to-business (B2B) products aimed at healthcare payers, providers, and pharmaceutical companies. Moreover, the investment will aid in creating a novel, data-driven self-care pathway designed to complement existing medical care frameworks while enhancing patient outcomes.
The innovative approach taken by Chiron Health AI is the result of the collaborative efforts of its co-founders, who include seasoned entrepreneurs Carron Manning, Davide Crescenzi, and Dr.
Karen Lawson. By harnessing the power of artificial intelligence, the company seeks to analyze patient data profiles and subsequently recommend personalized self-care interventions that demonstrate the highest potential for clinical success. These customized recommendations are meticulously designed to not only improve clinical outcomes but also empower patients to actively manage their chronic conditions. Ultimately, this approach aims to enhance value-based outcomes within healthcare systems, aligning with the modern focus on patient-centric care.
Carron Manning expressed the significance of the recent investment, stating, “This investment is a significant milestone in our journey to transform chronic disease management. By integrating personalized AI-driven and evidence-based self-care into existing medical pathways, we aim to deliver better outcomes for patients and unlock value for healthcare providers and payers.” The positive sentiment surrounding Chiron Health AI is echoed by Adam Beveridge, an Investment Associate at SFC Capital, who noted the startup’s innovative, data-driven approach to addressing critical needs in healthcare. This funding will enable Chiron Health AI to spearhead a transformation in chronic disease management, fundamentally reshaping how healthcare systems interact with long-term conditions while fostering clinical efficiency and empowering patients on their health journey.
They've invested in Chiron Health AI
Get to know these Healthtech investors
Click here for a full list of 6,481+ startup investors in the UK